IL18RAP Specific Recomb™ Antibody (V3S-1023-FY84), Human IgG (CAT#: V3S-1023-FY84)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This is an inhibitory monoclonal antibody that recognize human IL18RAP. IgG 3131 inhibited IFN-gamma secretion in a dose-dependent manner. It also prevented the formation of the ternary signaling complex by inhibiting the binding of soluble IL-18/IL-18Ra to immobilized IL-18Rb, as confirmed by ELISA.
Clonality Monoclonal
Host Species Human
Target Species Human
IC50 3 ± 2 nM (KG1 cell)
4 ± 2 nM (PBMC)
Isotype Human IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within a week. For longer storage, aliquot and store at -20°C.

Applications

Application ELISA; Inhib; FC; IF

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target IL18RAP
Alternative Name ACPL; CD218b; IL-1R7; IL18RB; CDw218b; IL-1R-7; IL-18RAcP; IL-1RAcPL; IL-18Rbeta; IL-18R-beta; interleukin-18 receptor accessory protein; CD218 antigen-like family member B; IL-18 receptor accessory protein; IL-18 receptor beta; cluster of differentiation w218b; interleukin-1 receptor 7; interleukin-18 receptor beta
Gene ID 8807
UniProt O95256
Research Area Immunology; Cancer Research; Autophagy
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry